Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors

類似資料

• Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours
  著者:: Campone, M, 等
  出版事項: (2009)
• Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients
  著者:: Li, Qingmei, 等
  出版事項: (2018)
• Pharmacokinetics, safety and tolerance of single- and multiple-dose adefovir dipivoxil in healthy Chinese subjects
  著者:: Sun, De-qing, 等
  出版事項: (2007)
• Pharmacokinetics of tolbutamide in ethnic Chinese
  著者:: Gross, Annette S, 等
  出版事項: (1999)
• A Phase I Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Patients with Select Advanced Solid Tumors
  著者:: Ma, Yuxiang, 等
  出版事項: (2020)